Molecular Mechanisms of Rett Syndrome
Author Information
Author(s): Gonçalez Julia Lopes, Shen Jenny, Li Wei
Primary Institution: University of Alabama at Birmingham
Hypothesis
This review explores the roles of monoamines, immunity, and mitochondrial dysfunction in the pathophysiology of Rett syndrome.
Conclusion
Targeting molecular pathways related to monoamines, immune dysfunction, and mitochondrial health may lead to effective therapies for Rett syndrome.
Supporting Evidence
- Rett syndrome is caused by mutations in the MECP2 gene, leading to multi-systemic issues.
- Monoamines such as dopamine and serotonin show altered levels in Rett syndrome patients.
- The immune system in Rett syndrome individuals demonstrates dysfunction, affecting inflammatory responses.
- Mitochondrial dysfunction is evident in Rett syndrome, impacting energy production and oxidative stress.
- Targeting these molecular pathways may provide new therapeutic options for Rett syndrome.
Takeaway
Rett syndrome is a condition that affects mostly girls and is caused by a gene mutation. This review looks at how certain brain chemicals, the immune system, and energy-producing parts of cells are involved in the disease.
Methodology
The review summarizes findings from literature searches conducted on various databases using specific keywords related to Rett syndrome and its molecular mechanisms.
Limitations
The review is based on existing literature and may not encompass all recent findings or studies.
Participant Demographics
Rett syndrome predominantly affects females, with an incidence of 1:10,000-15,000 births.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website